drs. Iris Hollink

Medicine & Life Sciences

1. High-Throughput Nucleotide Sequencing 100%
2. Severe Combined Immunodeficiency 66%
3. Inflammatory Bowel Diseases 65%
4. Neonatal Screening 61%
5. Netherlands 54%
6. Colitis 53%
7. Genome 53%
8. Colonic Diseases 49%
9. Interleukin-2 46%
10. Immunity 42%
11. Inflammation 40%
12. Observational Studies 40%
13. Phosphotransferases 40%
14. Cell Death 39%
15. Parents 39%
16. Colectomy 38%
17. Cohort Studies 35%
18. T-Cell Antigen Receptor 35%
19. T-Lymphocytes 32%
20. Genes 31%
21. Genetic Heterogeneity 30%
22. tofacitinib 27%
23. Transcription Factors 26%
24. Chromosome Duplication 25%
25. Interleukin-12 Subunit p40 24%
26. Macrophages 24%
27. CD4-CD8 Ratio 21%
28. Chemotactic Factors 19%
29. Duodenum 17%
30. Interleukin-1 17%
31. Intestines 15%
32. Ulcer 15%
33. Lipopolysaccharides 14%
34. Necroptosis 14%
35. Neutrophils 13%
36. Newborn Infant 13%
37. Fever 13%
38. Anti-Inflammatory Agents 12%
39. Memory 12%
40. Up-Regulation 12%
41. Tumor Necrosis Factor-alpha 12%
42. In Vitro Techniques 12%
43. Loss of Function Mutation 11%
44. Pathology 10%
45. Mutation 9%
46. Phagocytes 9%
47. Disease Management 8%
48. Pediatrics 8%
49. Interleukin-6 8%
50. Fibroblasts 7%